Merck & Co. (MRK)
(Delayed Data from NYSE)
$117.17 USD
-0.06 (-0.05%)
Updated Sep 20, 2024 04:01 PM ET
After-Market: $117.31 +0.14 (0.12%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 377.00 | 14,526.00 | 12,358.00 | 7,082.00 | 9,777.00 |
Depreciation/Amortization & Depletion | 3,872.00 | 3,909.00 | 3,214.00 | 3,625.00 | 3,652.00 |
Net Change from Assets/Liabilities | -2,205.00 | -2,782.00 | -3,839.00 | -4,590.00 | -2,067.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10,962.00 | 3,442.00 | 1,389.00 | 4,136.00 | 2,078.00 |
Net Cash From Operating Activities | 13,006.00 | 19,095.00 | 13,122.00 | 10,253.00 | 13,440.00 |
Property & Equipment | -3,863.00 | -4,388.00 | -4,448.00 | -4,684.00 | -3,473.00 |
Acquisition/ Disposition of Subsidiaries | -12,032.00 | -121.00 | -12,907.00 | -6,606.00 | -4,954.00 |
Investments | 1,848.00 | -483.00 | 1,025.00 | 2,717.00 | 5,420.00 |
Other Investing Activities | -36.00 | 32.00 | -91.00 | -870.00 | 378.00 |
Net Cash from Investing Activities | -14,083.00 | -4,960.00 | -16,421.00 | -9,443.00 | -2,629.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,221.00 | 384.00 | -638.00 | -1,192.00 | -4,419.00 |
Issuance (Repayment) of Debt | 4,184.00 | -2,251.00 | 5,617.00 | 2,462.00 | 4,958.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -3,986.00 | 2,549.00 | -3,710.00 |
Payment of Dividends & Other Distributions | -7,445.00 | -7,012.00 | -6,610.00 | -6,215.00 | -5,695.00 |
Other Financing Activities | -328.00 | -240.00 | 8,714.00 | -436.00 | 5.00 |
Net Cash from Financing Activities | -4,810.00 | -9,119.00 | 3,097.00 | -2,832.00 | -8,861.00 |
Effect of Exchange Rate Changes | 23.00 | -410.00 | 216.00 | 253.00 | 17.00 |
Net Change In Cash & Equivalents | -5,864.00 | 4,606.00 | 14.00 | -1,769.00 | 1,967.00 |
Cash at Beginning of Period | 12,773.00 | 8,167.00 | 8,153.00 | 9,934.00 | 7,967.00 |
Cash at End of Period | 6,909.00 | 12,773.00 | 8,167.00 | 8,165.00 | 9,934.00 |
Diluted Net EPS | 0.14 | 5.71 | 5.14 | 2.78 | 3.81 |
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 10,228.00 | 4,767.00 | 377.00 | 1,603.00 | -3,147.00 |
Depreciation/Amortization & Depletion | 2,116.00 | 984.00 | 3,872.00 | 2,908.00 | 1,894.00 |
Net Change from Assets/Liabilities | -4,394.00 | -3,382.00 | -2,205.00 | -2,349.00 | -4,526.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 777.00 | 721.00 | 10,962.00 | 10,598.00 | 10,822.00 |
Net Cash From Operating Activities | 8,727.00 | 3,090.00 | 13,006.00 | 12,760.00 | 5,043.00 |
Property & Equipment | -1,652.00 | -861.00 | -3,863.00 | -2,874.00 | -1,972.00 |
Acquisition/ Disposition of Subsidiaries | -746.00 | -746.00 | -12,032.00 | -12,032.00 | -12,032.00 |
Investments | 256.00 | 245.00 | 1,848.00 | 785.00 | 198.00 |
Other Investing Activities | -303.00 | -14.00 | -36.00 | -15.00 | 4.00 |
Net Cash from Investing Activities | -2,445.00 | -1,376.00 | -14,083.00 | -14,136.00 | -13,802.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -213.00 | -35.00 | -1,221.00 | -834.00 | -375.00 |
Issuance (Repayment) of Debt | 2,849.00 | -751.00 | 4,184.00 | 4,187.00 | 4,195.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1,937.00 |
Payment of Dividends & Other Distributions | -3,936.00 | -1,950.00 | -7,445.00 | -5,593.00 | -3,738.00 |
Other Financing Activities | -298.00 | -78.00 | -328.00 | -325.00 | -315.00 |
Net Cash from Financing Activities | -1,598.00 | -2,814.00 | -4,810.00 | -2,565.00 | 1,704.00 |
Effect of Exchange Rate Changes | -220.00 | -138.00 | 23.00 | -163.00 | -6.00 |
Net Change In Cash & Equivalents | 4,464.00 | -1,238.00 | -5,864.00 | -4,104.00 | -7,061.00 |
Cash at Beginning of Period | 6,909.00 | 6,909.00 | 12,773.00 | 12,773.00 | 12,773.00 |
Cash at End of Period | 11,373.00 | 5,671.00 | 6,909.00 | 8,669.00 | 5,712.00 |
Diluted Net EPS | 2.14 | 1.87 | -0.48 | 1.86 | -2.35 |